Showing results (1-10 of 227) with videos related to
Sort By:
Pageof 23
Viruses|January 19, 2018
Resistance to HIV Integrase Inhibitors: About R263K and E157Q MutationsCharlotte Charpentier, Diane DescampsInfection and Drug Resistance|June 23, 2011
Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapyCharlotte Charpentier, Laurence WeissVirologie (Montrouge, France)|March 6, 2026
[Cervical cancer screening: what role for methylation tests?]Charlotte Charpentier, Julie Brousseau, Aude Jary, et al.Future Microbiology|July 30, 2011
Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicideLaurent Bélec, Mohammad-Ali Jenabian, Charlotte Charpentier, et al.Virologie (Montrouge, France)|January 9, 2020
Antiretroviral treatments in 2012: improvements and future prospectsCharlotte Charpentier, Véronique Joly, Patrick Yeni, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 18, 2016
Hiv-2 molecular epidemiologyBenoit Visseaux, Florence Damond, Sophie Matheron, et al.The Journal of Antimicrobial Chemotherapy|November 2, 2017
HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot studyCharlotte Charpentier, Brigitte Montes, Marine Perrier, et al.AIDS Research and Human Retroviruses|October 28, 2010
Virological failure and HIV type 1 drug resistance profiles among patients followed-up in private sector, Douala, CameroonCharlotte Charpentier, Frédéric Talla, Evelyne Nguepi, et al.Journal of Virology|February 14, 2006
Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patientsCharlotte Charpentier, Tamara Nora, Olivier Tenaillon, et al.Virologie (Montrouge, France)|December 13, 2019
[Physiopathology of HIV-2 infection]Benoît Visseaux, Quentin Le Hingrat, Florence Damond, et al.Pageof 23